INSPQ
Published on INSPQ (https://www.inspq.qc.ca)

Home > Site Map

  • The Institute [1]
    • About us [2]
      • Three areas of expertise [3]
      • Products and services offered [4]
      • Clients [5]
    • Contact us [6]
  • Expertise [7]
    • Indigenous Health [8]
      • Methodology for Indigenous Health Research Monitoring [9]
      • Nunavik Inuit Health Survey [10]
    • Environmental health and toxicology [11]
      • Centre de toxicologie du Québec [12]
      • Mould compendium [13]
        • Moulds fact sheets [14]
          • Absidia corymbifera [15]
          • Acremonium spp. [16]
          • Alternaria alternata [17]
          • Aspergillus flavus [18]
          • Aspergillus fumigatus [19]
          • Aspergillus niger [20]
          • Aureobasidium pullulans [21]
          • Chaetomium spp. [22]
          • Cladosporium cladosporioides [23]
          • Cladosporium herbarum [24]
          • Epicoccum purpurascens [25]
          • Fusarium spp. [26]
          • Penicillium spp. [27]
          • Phoma glomerata [28]
          • Stachybotrys chartarum [29]
          • Ulocladium chartarum [30]
        • Terms of use [31]
        • Your health [32]
        • Your home [33]
    • Individual and community development [34]
      • From Tiny Tot to Toddler [35]
        • Consultation [36]
        • Buy the guide [37]
    • Infectious diseases [38]
      • Blood-Borne Infection Risk Assessment Unit [39]
        • Assessment Process [40]
        • Assessment Request Pathway [41]
        • Exposure-Prone Procedures and Limitation Thresholds [42]
        • Rights and Responsibilities [43]
        • SERTIH's Team [44]
        • For More Information [45]
      • Nosocomial infections [46]
        • Carbapenemase-Producing Gram Negative Bacilli (CPGNB) Infections [47]
          • 2014–2015 [48]
          • 2015-2016 [49]
          • 2016-2017 [50]
        • Central Line–Associated Bloodstream Infections in Intensive Care Units [51]
          • 2012-2013 [52]
          • 2013-2014 [53]
          • 2014–2015 [54]
          • 2015-2016 [55]
          • 2016-2017 [56]
        • Clostridium difficile–Associated Diarrhea (CDAD) [57]
          • 2012-2013 [58]
          • 2013–2014 [59]
          • 2014–2015 [60]
          • 2015-2016 [61]
          • 2016-2017 [62]
        • Hospital-Wide Healthcare-associated Bloodstream Infections [63]
          • 2012-2013 [64]
          • 2013-2014 [65]
          • 2014–2015 [66]
          • 2015-2016 [67]
          • 2016-2017 [68]
        • Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections [69]
          • 2012-2013 [70]
          • 2013–2014 [71]
          • 2014–2015 [72]
          • 2015-2016 [73]
          • 2016-2017 [74]
        • Vancomycin-Resistant Enterococci (VRE) Infections [75]
          • 2012-2013 [76]
          • 2013–2014 [77]
          • 2014–2015 [78]
          • 2015-2016 [79]
          • 2016-2017 [80]
        • Vascular Access–Related Bloodstream Infections in Hemodialysis Patients [81]
          • 2012-2013 [82]
          • 2013-2014 [83]
          • 2014–2015 [84]
          • 2015-2016 [85]
          • 2016-2017 [86]
      • Travel Health [87]
        • Atovaquone-Proguanil [88]
        • Chloroquine [89]
        • Doxycycline [90]
        • Malaria [91]
        • Mefloquine [92]
        • Primaquine [93]
        • Travelers' diarrhea [94]
        • Yellow Fever [95]
      • COVID-19 (coronavirus) [96]
        • Environment and public places [97]
          • Surface cleaning [98]
        • Infection prevention and control [99]
        • Occupational health [100]
      • Identification guide for ticks found in Québec [101]
      • Informative pamphlets: Lyme disease in the workplace [102]
    • Lifestyles and prevention of chronic illnesses [103]
      • Science Watch : Tobacco Control [104]
      • TOPO [105]
      • Opioid Overdoses [106]
        • Naloxone administration [107]
        • Resources that can provide Naloxone [108]
    • Occupational health [109]
      • Asbestos [110]
        • Additional information on Asbestos in Québec [111]
      • Tool for Identifying Psychosocial Risk Factors in the Workplace [112]
    • Safety, violence and injury prevention [113]
      • Charting a course to safe living collection [114]
      • Media Kit on Sexual Assault [115]
      • Québec Collaborating Centre for Safety Promotion and Injury Prevention [116]
        • Definition of the concept of safety [117]
        • Mandate [118]
        • Organisation [119]
        • Activities [120]
      • Violence in Indigenous communities in brief [121]
      • Mistreatment of Older Adults [122]
    • Information management and analysis [123]
      • Deprivation [124]
        • Material and Social Deprivation Index [125]
          • Methodological documents MSDI [126]
        • Indices of multiple and multidimensional deprivation [127]
      • Deprivation Index [128]
        • Deprivation index, Canada, 2016 [129]
        • Deprivation index, Canada, 2011 [130]
        • Deprivation index, Canada, 2006 [131]
        • Deprivation index, Canada, 2001 [132]
        • Deprivation index, Canada, 1996 [133]
        • Deprivation index, Canada, 1991 [134]
      • Health Profile of Linguistic Communities in Québec [135]
  • Publications [136]


© Gouvernement du Québec, 2021


Source URL (retrieved on 01/27/2021 - 19:41): https://www.inspq.qc.ca/en/sitemap

Links
[1] https://www.inspq.qc.ca/en/institute
[2] https://www.inspq.qc.ca/en/institute/about-us
[3] https://www.inspq.qc.ca/en/institute/about-us/three-areas-expertise
[4] https://www.inspq.qc.ca/en/institute/about-us/products-and-services-offered
[5] https://www.inspq.qc.ca/en/institute/about-us/clients
[6] https://www.inspq.qc.ca/en/institute/contact-us
[7] https://www.inspq.qc.ca/en/expertise
[8] https://www.inspq.qc.ca/en/indigenous-health
[9] https://www.inspq.qc.ca/en/aboriginal-health/methodology%20for%20research%20monitoring
[10] https://www.inspq.qc.ca/en/aboriginal-health/nunavik-inuit-health-survey-2004
[11] https://www.inspq.qc.ca/en/environmental-health-and-toxicology
[12] https://www.inspq.qc.ca/en/ctq/home
[13] https://www.inspq.qc.ca/en/moulds
[14] https://www.inspq.qc.ca/en/moulds/fact-sheets
[15] https://www.inspq.qc.ca/en/moulds/fact-sheets/absidia-corymbifera
[16] https://www.inspq.qc.ca/en/moulds/fact-sheets/acremonium-spp
[17] https://www.inspq.qc.ca/en/moulds/fact-sheets/alternaria-alternata
[18] https://www.inspq.qc.ca/en/moulds/fact-sheets/aspergillus-flavus
[19] https://www.inspq.qc.ca/en/moulds/fact-sheets/aspergillus-fumigatus
[20] https://www.inspq.qc.ca/en/moulds/fact-sheets/aspergillus-niger
[21] https://www.inspq.qc.ca/en/moulds/fact-sheets/aureobasidium-pullulans
[22] https://www.inspq.qc.ca/en/moulds/fact-sheets/chaetomium-spp
[23] https://www.inspq.qc.ca/en/moulds/fact-sheets/cladosporium-cladosporioides
[24] https://www.inspq.qc.ca/en/moulds/fact-sheets/cladosporium-herbarum
[25] https://www.inspq.qc.ca/en/moulds/fact-sheets/epicoccum-purpurascens
[26] https://www.inspq.qc.ca/en/moulds/fact-sheets/fusarium-spp
[27] https://www.inspq.qc.ca/en/moulds/fact-sheets/penicillium-spp
[28] https://www.inspq.qc.ca/en/moulds/fact-sheets/phoma-glomerata
[29] https://www.inspq.qc.ca/en/moulds/fact-sheets/stachybotrys-chartarum
[30] https://www.inspq.qc.ca/en/moulds/fact-sheets/ulocladium-chartarum
[31] https://www.inspq.qc.ca/en/moulds/terms-of-use
[32] https://www.inspq.qc.ca/en/moulds/your-health
[33] https://www.inspq.qc.ca/en/moulds/your-home
[34] https://www.inspq.qc.ca/en/individual-and-community-development
[35] https://www.inspq.qc.ca/en/tiny-tot
[36] https://www.inspq.qc.ca/en/tiny-tot/consultation
[37] https://www.inspq.qc.ca/en/tiny-tot/buy
[38] https://www.inspq.qc.ca/en/infectious-diseases
[39] https://www.inspq.qc.ca/en/blood-borne-infection-risk-assessment-unit
[40] https://www.inspq.qc.ca/en/blood-borne-infection-risk-assessment-unit/assessment-process
[41] https://www.inspq.qc.ca/en/blood-borne-infection-risk-assessment-unit/assessment-request-pathway
[42] https://www.inspq.qc.ca/en/blood-borne-infection-risk-assessment-unit/exposure-prone-procedures-and-limitation-thresholds
[43] https://www.inspq.qc.ca/en/blood-borne-infection-risk-assessment-unit/rights-and-responsibilities
[44] https://www.inspq.qc.ca/en/blood-borne-infection-risk-assessment-unit/sertih-s-team
[45] https://www.inspq.qc.ca/en/blood-borne-infection-risk-assessment-unit/more-information
[46] https://www.inspq.qc.ca/en/expertise/infectious-diseases/nosocomial-infections
[47] https://www.inspq.qc.ca/en/nosocomial-infections/carbapenemase-producing-gram-negative-bacilli-cpgnb-infections
[48] https://www.inspq.qc.ca/en/nosocomial-infections/spin-bgnpc/surveillance-results-2014-2015
[49] https://www.inspq.qc.ca/en/nosocomial-infections/spin-bgnpc/surveillance-results-2015-2016
[50] https://www.inspq.qc.ca/en/nosocomial-infections/spin-bgnpc/surveillance-results-2016-2017
[51] https://www.inspq.qc.ca/en/nosocomial-infections/central-line-associated-bloodstream-infections-intensive-care-units
[52] https://www.inspq.qc.ca/en/publications/1880
[53] https://www.inspq.qc.ca/en/nosocomial-infections/spin-bacc/surveillance-results-2013-2014
[54] https://www.inspq.qc.ca/en/nosocomial-infections/spin-bacc/surveillance-results-2014-2015
[55] https://www.inspq.qc.ca/en/nosocomial-infections/spin-bacc/surveillance-results-2015-2016
[56] https://www.inspq.qc.ca/en/nosocomial-infections/spin-bacc/surveillance-results-2016-2017
[57] https://www.inspq.qc.ca/en/nosocomial-infections/clostridium-difficile-associated-diarrhea-cdad
[58] https://www.inspq.qc.ca/en/publications/1878
[59] https://www.inspq.qc.ca/en/nosocomial-infections/spin-cd/surveillance-results-2013-2014
[60] https://www.inspq.qc.ca/en/nosocomial-infections/spin-cdad/surveillance-results-2014-2015
[61] https://www.inspq.qc.ca/en/nosocomial-infections/spin-cdad/surveillance-results-2015-2016
[62] https://www.inspq.qc.ca/en/nosocomial-infections/spin-cdad/surveillance-results-2016-2017
[63] https://www.inspq.qc.ca/en/nosocomial-infections/hospital-wide-healthcare-associated-bloodstream-infections
[64] https://www.inspq.qc.ca/en/publications/1879
[65] https://www.inspq.qc.ca/en/nosocomial-infections/spin-bactot/surveillance-results-2013-2014
[66] https://www.inspq.qc.ca/en/nosocomial-infections/spin-bactot/surveillance-results-2014-2015
[67] https://www.inspq.qc.ca/en/nosocomial-infections/spin-bactot/surveillance-results-2015-2016
[68] https://www.inspq.qc.ca/en/nosocomial-infections/spin-bactot/surveillance-results-2016-2017
[69] https://www.inspq.qc.ca/en/nosocomial-infections/methicillin-resistant-staphylococcus-aureus-mrsa-bloodstream-infections
[70] https://www.inspq.qc.ca/en/publications/1877
[71] https://www.inspq.qc.ca/en/nosocomial-infections/spin-mrsa/surveillance-results-2013-2014
[72] https://www.inspq.qc.ca/en/nosocomial-infections/spin-mrsa/surveillance-results-2014-2015
[73] https://www.inspq.qc.ca/en/nosocomial-infections/spin-mrsa/surveillance-results-2015-2016
[74] https://www.inspq.qc.ca/en/nosocomial-infections/spin-mrsa/surveillance-results-2016-2017
[75] https://www.inspq.qc.ca/en/nosocomial-infections/vancomycin-resistant-enterococci-vre-infections
[76] https://www.inspq.qc.ca/en/publications/1876
[77] https://www.inspq.qc.ca/en/nosocomial-infections/spin-vre/surveillance-results-2013-2014
[78] https://www.inspq.qc.ca/en/nosocomial-infections/spin-vre/surveillance-results-2014-2015
[79] https://www.inspq.qc.ca/en/nosocomial-infections/spin-vre/surveillance-results-2015-2016
[80] https://www.inspq.qc.ca/en/nosocomial-infections/spin-vre/surveillance-results-2016-2017
[81] https://www.inspq.qc.ca/en/nosocomial-infections/vascular-access-related-bloodstream-infections-hemodialysis-patients
[82] https://www.inspq.qc.ca/en/publications/1881
[83] https://www.inspq.qc.ca/en/nosocomial-infections/spin-bachd/surveillance-results-2013-2014
[84] https://www.inspq.qc.ca/en/nosocomial-infections/spin-bachd/surveillance-results-2014-2015
[85] https://www.inspq.qc.ca/en/nosocomial-infections/spin-bachd/surveillance-results-2015-2016
[86] https://www.inspq.qc.ca/en/nosocomial-infections/spin-bachd/surveillance-results-2016-2017
[87] https://www.inspq.qc.ca/en/travel-health
[88] https://www.inspq.qc.ca/en/travel-health/atovaquone-proguanil
[89] https://www.inspq.qc.ca/en/travel-health/chloroquine
[90] https://www.inspq.qc.ca/en/travel-health/doxycycline
[91] https://www.inspq.qc.ca/en/travel-health/malaria
[92] https://www.inspq.qc.ca/en/travel-health/mefloquine
[93] https://www.inspq.qc.ca/en/travel-health/primaquine
[94] https://www.inspq.qc.ca/en/travel-health/travelers-diarrhea
[95] https://www.inspq.qc.ca/en/travel-health/yellow-fever
[96] https://www.inspq.qc.ca/en/covid-19
[97] https://www.inspq.qc.ca/en/covid-19/environment
[98] https://www.inspq.qc.ca/en/covid-19/environment/surface-cleaning
[99] https://www.inspq.qc.ca/en/covid-19/infection-prevention-and-control
[100] https://www.inspq.qc.ca/en/covid-19/occupational-health
[101] https://www.inspq.qc.ca/en/identification-guide-ticks-found-quebec
[102] https://www.inspq.qc.ca/en/expertise/infectious-diseases/informative-pamphlets-lyme-disease-workplace
[103] https://www.inspq.qc.ca/en/lifestyles-and-prevention-chronic-illnesses
[104] https://www.inspq.qc.ca/en/science-watch-tobacco-control/september-2020
[105] https://www.inspq.qc.ca/en/topo
[106] https://www.inspq.qc.ca/en/opioid-overdoses
[107] https://www.inspq.qc.ca/en/opioid-overdoses/naloxone-administration
[108] https://www.inspq.qc.ca/sites/default/files/cartes/naloxone/index.html
[109] https://www.inspq.qc.ca/en/occupational-health
[110] https://www.inspq.qc.ca/en/asbestos
[111] https://www.inspq.qc.ca/en/asbestos/additional-information-asbestos-quebec
[112] https://www.inspq.qc.ca/en/tool-identifying-psychosocial-risk-factors-workplace
[113] https://www.inspq.qc.ca/en/safety-violence-and-injury-prevention
[114] https://www.inspq.qc.ca/en/expertise/safety-violence-and-injury-prevention/charting-course-safe-living-collection
[115] https://www.inspq.qc.ca/en/sexual-assault/home
[116] https://www.inspq.qc.ca/en/quebec-collaborating-centre-safety-promotion-and-injury-prevention
[117] https://www.inspq.qc.ca/en/quebec-collaborating-centre-safety-promotion-and-injury-prevention/definition-concept-safety
[118] https://www.inspq.qc.ca/en/quebec-collaborating-centre-safety-promotion-and-injury-prevention/mandate
[119] https://www.inspq.qc.ca/en/quebec-collaborating-centre-safety-promotion-and-injury-prevention/organisation
[120] https://www.inspq.qc.ca/en/quebec-collaborating-centre-safety-promotion-and-injury-prevention/activities
[121] https://www.inspq.qc.ca/en/violence-indigenous-communities-brief
[122] https://www.inspq.qc.ca/en/mistreatment-older-adults
[123] https://www.inspq.qc.ca/en/information-management-and-analysis
[124] https://www.inspq.qc.ca/en/deprivation
[125] https://www.inspq.qc.ca/en/deprivation/material-and-social-deprivation-index
[126] https://www.inspq.qc.ca/en/deprivation/material-and-social-deprivation-index/methodological-documents-msdi
[127] https://www.inspq.qc.ca/en/deprivation/indices-multiple-and-multidimensional-deprivation
[128] https://www.inspq.qc.ca/en/information-management-and-analysis/deprivation-index
[129] https://www.inspq.qc.ca/en/expertise/information-management-and-analysis/deprivation-index/deprivation-index-canada-2016
[130] https://www.inspq.qc.ca/en/expertise/information-management-and-analysis/deprivation-index/deprivation-index-canada-2011
[131] https://www.inspq.qc.ca/en/expertise/information-management-and-analysis/deprivation-index/deprivation-index-canada-2006
[132] https://www.inspq.qc.ca/en/expertise/information-management-and-analysis/deprivation-index/deprivation-index-canada-2001
[133] https://www.inspq.qc.ca/en/expertise/information-management-and-analysis/deprivation-index/deprivation-index-canada-1996
[134] https://www.inspq.qc.ca/en/expertise/information-management-and-analysis/deprivation-index/deprivation-index-canada-1991
[135] https://www.inspq.qc.ca/en/expertise/information-management-and-analysis/health-profile-linguistic-communities-quebec
[136] https://www.inspq.qc.ca/en/publications/latest